The global healthcare industry is entering a period of profound transformation. Geopolitical realignments, economic pressure, and regulatory change are reshaping how pharmaceutical and medical device companies design, develop, manufacture and distribute products.
For MedTech innovators and their partners, anticipating these shifts is no longer optional; it’s a prerequisite for sustainable growth, writes Tom Oakley (pictured), VP of Strategic Partnerships at Sanner.
A changing global landscape
Several powerful macro trends are converging. Ageing populations, the rise of chronic diseases and the continued growth of biologics are driving long-term demand for innovative drug delivery and medical devices.
At the same time, the boundary between consumer products and medical devices continues to blur, with usability and patient experience becoming critical differentiators.
Overlaying these trends is an accelerating shift toward outsourcing.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.